Cooper Companies | COO - الربح الإجمالي على المبيعات

سعر السهم
69.97
التغيير اليومي
-0.74 -1.05%
شهريا
-15.64%
سنويا
-14.37%
Q1 التوقعات
67.81




الربح الإجمالي على المبيعات تغيير تاريخ
Abbott USD 6.54B 625M 2025-12
Align Technology USD 683.59M 44.39M 2025-12
AtriCure USD 105.34M 4M 2025-12
Avanos Medical USD 86M 0 2025-12
Bausch Health Companies USD 1.93B 165M 2025-09
Baxter International USD 577M 373M 2025-12
Bayer EUR 5.35B 1.02B 2025-09
Becton, Dickinson and Co. USD 2.41B 1.72B 2025-12
Boston Scientific USD 3.68B 136M 2025-12
Cooper Companies USD 695.2M 44.4M 2025-12
Dentsply International USD 443M 2M 2025-12
Dexcom USD 792.7M 61.3M 2025-12
Edwards Lifesciences USD 1.23B 18.7M 2025-12
Globus Medical USD 535.95M 49.28M 2025-12
Haemonetics USD 202.39M 7.64M 2025-12
Hologic USD 586.4M 2.9M 2025-12
Inogen USD 41.34M 1.39M 2024-09
Insulet USD 568.6M 58.5M 2025-12
Integra LifeSciences USD 217.1M 10.11M 2025-12
Intuitive Surgical USD 1.9B 241.9M 2025-12
J&J USD 16.6B 118M 2025-12
Medtronic USD 5.41B 27M 2025-12
Merit Medical Systems USD 195.35M 8.94M 2025-12
Novartis USD 10.82B 694M 2025-09
ResMed USD 878.72M 57.9M 2025-12
STAAR Surgical USD 43.74M 34.13M 2025-12
Steris USD 655.5M 9.6M 2025-12
Stryker USD 4.49B 633M 2025-12
Tandem Diabetes Care USD 167.46M 33.17M 2025-12
Teleflex USD 307.45M 144.2M 2025-12
Utah Medical Products USD 5.8M 450K 2024-09
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12